SCHEMBL5378636

SCHEMBL5378636

O=C(O)Cc1cc2c(CS)c[nH]c2cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
TSHR P16473 2/20 0.49
ALDH1A1 P00352 2/20 0.49
CYP2C9 P11712 2/20 0.49
NFKB1 P19838 2/20 0.49
HPGD P15428 2/20 0.49
GLA P06280 1/20 0.49
PMP22 Q01453 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
KDM4E B2RXH2 2/20 0.45
GPR84 Q9NQS5 1/20 0.42
GPR17 Q13304 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 3/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
THRB P10828 1/20 0.39
DNMT1 P26358 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5915286 0.83 ALDH1A1 (0.59) LMNATSHRALDH1A1CYP2C9NFKB1
SCHEMBL8800942 0.78 CSNK2A1 (0.58) LMNATSHRALDH1A1CYP2C9NFKB1
SCHEMBL5378634 0.77 LMNA (0.40) LMNATSHRALDH1A1CYP2C9NFKB1
SCHEMBL27569328 0.77 ALDH1A1 (0.52) LMNATSHRALDH1A1CYP2C9NFKB1
SCHEMBL5204235 0.73 NR4A2 (0.50) LMNACYP2C9NFKB1HPGDNPSR1
SCHEMBL27033587 0.72 TSHR (0.49) LMNATSHRALDH1A1CYP2C9NFKB1
SCHEMBL8577532 0.71 KDM4E (0.59) LMNATSHRALDH1A1CYP2C9NFKB1
SCHEMBL22678670 0.71 ALDH1A1 (0.66) LMNATSHRALDH1A1CYP2C9NFKB1
SCHEMBL1615011 0.71 TSHR (0.69) LMNATSHRALDH1A1CYP2C9NFKB1
SCHEMBL840736 0.71 GPR84 (0.65) LMNATSHRALDH1A1CYP2C9NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
US-6340685-B1 ANTIINFLAMMATORY AGENTS SCIOS, INC. 2002-01-22 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed